Puration with Kali-Extracts Initiate Production of New 25 mg CBD Beverage Under $1.5 Million Contract
June 18 2019 - 9:10AM
InvestorsHub NewsWire
Puration with Kali-Extracts
Initiate Production of New 25 mg CBD Beverage Under $1.5 Million
Contract
Dallas, TX -- June 18, 2019 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) (”PURA”) and Kali-Extracts, Inc. (aka Kali, Inc.)
(USOTC:
KALY) (“KALY”) today announced initiating production of a new
beverage infused with 25 mg of hemp derived CBD. Most CBD infused
beverages contain only 5 mg of CBD with a few containing 10
mg. Beverages with 25 mg of CBD are hard to find. PURA
has been producing a CBD infused sports water infused with 10 mg of
CBD since 2017. PURA markets and sells the CBD sports water
under the brand name EVERx and achieved over $1 million in sales in
2018. PURA has the sole license of KALY’s U.S. Patented
Cannabis Extraction Process. PURA and KALY have partnered on
the development of a CBD extraction that can support a clear and
sustained suspension at the 25 mg level. As of today, the
production of a 25 mg CBD beverage has been initiated for
production at a Texas facility. Texas Governor
Greg Abbott signed a new law last
week legalizing hemp and hemp-derived
products. The 25 mg CBD beverage is being
produced in fulfillment of a $1.5 million contract where PURA is
producing the beverage under a private label for a third
party. PURA has in turn engaged KALY for its extract
expertise.
PURA Speculative Buy Recommendation and
$0.25 PPS Target w/Potential to
$0.35
Goldman Small Cap Research has released a
new research report recommending PURA as a Speculative
BUY with a $0.25 PPS Target. Goldman Small Cap Research further
reports that the shares of PURA “have the potential to reach the
$0.35 mark.” The report highlights PURA’s growing EVERx CBD
Sports Water sales and the coming introduction of new beverages as
well as the potential for the company to exceed its 2019 sales
targets through the pending doubling of its production capacity and
through planned acquisitions. The report further details
recent updates intended to accelerate the issue of Nouveau (USOTC:
NOUV) stock to PURA shareholders in a dividend distribution.
Notably, the report points to the capacity and quality improvements
enabled by the addition of a new team member with exceptional
beverage industry professional
experience.
For more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Apr 2023 to Apr 2024